tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Balaji Prasad, 23 are a SELL (11.39%), 18 are a HOLD (8.91%), 161 are a BUY (79.7%).
Analyst Balaji Prasad, currently employed at BARCLAYS, carries an average stock price target met ratio of 51.23% that have a potential upside of 22.18% achieved within 232 days.
Balaji Prasad’s has documented 412 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EOLS, Evolus at 04-Mar-2025.
Analyst best performing recommendations are on MNK (MALLINCKRODT PLC).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $123.52 was fulfilled within 1 day with a profit of $11.16 (9.93%) receiving and performance score of 99.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$10
$3.95 (65.29%)
$10
5 months 13 days ago
(02-May-2025)
12/25 (48%)
$4.58 (84.50%)
252
Hold
$8
$1.95 (32.23%)
$10
8 months 9 days ago
(05-Feb-2025)
1/4 (25%)
$1.46 (22.32%)
190
Sell
$3
$-3.05 (-50.41%)
$9
1 years 2 months 13 days ago
(02-Aug-2024)
11/14 (78.57%)
$-2.63 (-46.71%)
201
Hold
$7
$0.95 (15.70%)
1 years 2 months 20 days ago
(25-Jul-2024)
1/1 (100%)
$1.12 (19.05%)
53
Buy
$16
$9.95 (164.46%)
$9.5
2 years 25 days ago
(20-Sep-2023)
4/5 (80%)
$7.66 (91.85%)
143
What Year was the first public recommendation made by Balaji Prasad?
